MAA
IART icon

Mraz Amerine & Associates’s Integra LifeSciences IART Stock Holding History

Mraz Amerine & Associates’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Hold
10,700
– – 0.03% 179
2026
Q1 		$101K Buy
+10,700
New +$117K 0.01% 181

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mraz Amerine & Associates's IART Position: Q2 2026 in Review

Mraz Amerine & Associates held its Integra LifeSciences (IART) position steady in Q2 2026 at 10,700 shares worth $192K. The position accounts for 0.03% of the portfolio, ranked #179.

Mraz Amerine & Associates first reported a position in IART in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Mraz Amerine & Associates held 10,700 shares of Integra LifeSciences worth $192K as of Q2 2026.
  • Mraz Amerine & Associates left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up 0.03% of Mraz Amerine & Associates's portfolio in Q2 2026, its #179 holding.
  • Mraz Amerine & Associates first reported a position in Integra LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.